Subscribe to our Newsletters !!
The safety and quality of produced medicines is ex
The use of the Greek letter sigma (Σ, σ) extends
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
2026 marks a new chapter for the pharmaceutical an
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-look
Drug firm Jubilant Life Sciences on Saturday said it has introduced 1,000 vials of antiviral drug Remdesivir that it sells under the brand name’JUBI-R’ into Uttar Pradesh Chief Minister Yogi Adityanath.
The drug has been made accessible to over 1,000 hospitals supplying COVID-19 treatment in India throughout the organization’s distribution system, Jubilant Life Sciences said in a statement.
“Remdesivir is an effective medication in the treatment of severe COVID-19 instances. In this critical situation, I am pleased that this medicine was made available by Jubilant at the brief period of 2 and a half a year,” the firm quoted Adityanath as stating.
In May 2020,” Jubilant entered into a non-exclusive licensing agreement with Gilead Sciences, Inc., which granted it the right to enroll, fabricate and promote Gilead’s investigational drug remdesivir in 127 countries including India, the company said.
